Co-led Sightera Biosciences' €3M pre-seed round alongside Anacura and QBIC. Sightera is an Antwerp-based AI drug discovery startup using patient-derived biology data.
Sightera Biosciences pioneers clinically correlated drug-response data to power generative drug design, focusing on AI-designed small molecules derived from therapy-resistant and end-stage patient tissues
Sightera Biosciences pioneers clinically correlated drug-response data to power generative drug design, focusing on AI-designed small molecules derived from therapy-resistant and end-stage patient tissues.